
What you should expect from a first visit
A thorough first visit covers your cycle history, the symptoms that bother you most, sleep, mood, sexual and urinary health, and your personal and family history of blood clots, stroke, heart disease and breast or endometrial cancer. It should end with a clear explanation of options, including non-hormonal ones.
Because hormone levels swing during perimenopause, a careful clinician will not rely on one blood test to decide whether you are in the transition. Labs are useful to rule out thyroid problems, anemia and other lookalikes, and to set a baseline for heart and metabolic health.
What good looks like
- Clinicians with specific training or experience in menopause care
- Individualized discussion of benefits and risks, including the effect of age and time since menopause
- Transdermal estrogen discussed for women with clot, migraine or metabolic concerns
- A progestogen included for anyone with a uterus who takes systemic estrogen
- Vaginal estrogen and non-hormonal options offered for genitourinary symptoms
- Clear labeling of FDA-approved versus compounded products
- An annual review of whether to continue, adjust or stop
Red flags
- A diagnosis of hormone imbalance based on a single blood or saliva test
- Custom-compounded hormones presented as safer or more natural than approved products
- Pellets as the default, with no discussion of how hard doses are to adjust
- Estrogen without a progestogen for a woman who still has a uterus
- No questions about breast cancer, clots or stroke history
- Promises that hormones will prevent aging, dementia or weight gain
- Supplements sold alongside every prescription
What the evidence says about risk today
The Menopause Society's position is that for healthy women under 60 or within 10 years of menopause with bothersome symptoms, the benefits of hormone therapy generally outweigh the risks. In February 2026, FDA approved labeling changes that removed cardiovascular disease, breast cancer and probable dementia statements from the boxed warning on several menopausal hormone products. Risks still exist and should be discussed for your situation, especially if you start later or have certain medical histories.
Telehealth works for much of menopause care
Most menopause care is conversation: understanding symptoms, weighing options, adjusting doses and reviewing how you feel. That makes it well suited to video or online visits. Some issues still need an in-person exam, including any bleeding after menopause, unexpected heavy bleeding on therapy, a breast lump or pelvic pain. A good service will be clear about this and will expect you to stay current with mammograms and cervical screening locally.
It also helps if the clinic can share notes with your primary care clinician or gynecologist, so your care is not split across disconnected providers.
Symptoms a good clinic should ask about
Hot flashes are the headline, but a thorough clinic asks about the full range: sleep disruption and early waking, anxiety and irritability, word-finding trouble, joint pain, palpitations, heavier or irregular bleeding, dryness and pain with sex, and urinary urgency or repeat infections. Many women do not connect these with hormones until someone asks. A clinic that only asks about hot flashes may miss what bothers you most.
Longevity add-ons: ask for the evidence
Many midlife clinics also sell longevity services, from advanced lab panels to peptides and NAD+. Some testing, such as lipoprotein(a) and ApoB, can genuinely sharpen heart risk assessment. Other offerings have limited human evidence. A trustworthy clinic separates the two clearly and does not make hormone care conditional on buying extras.
Questions to ask
- What training do your clinicians have in menopause care?
- How do you decide whether I am in perimenopause?
- Which products are FDA-approved and which are compounded, and why would you choose one over the other for me?
- How will you protect my uterine lining if I take estrogen?
- What are my options if I cannot or do not want to use hormones?
- How often will we review my plan?
Applying this to HealifyMD
HealifyMD content is medically reviewed by Dr. Vanessa Niles, a board-certified OB-GYN with more than 40 years in women's health. You can hold us to the same criteria. Our hormone therapy plan is listed at $349 for the first month, then $99 per month, and includes estradiol and progesterone options; some are compounded and therefore not FDA-approved. The first month includes baseline labs, and prices are confirmed during your eligibility review.
Common questions
Can a blood test tell a clinic whether I need HRT?
Not on its own. HRT decisions are based mainly on symptoms, age, time since menopause and health history; labs mostly rule out other causes.
Are compounded bioidentical hormones safer?
There is no good evidence that they are. The National Academies recommended reserving them for people who cannot use an FDA-approved product.
Why is progesterone needed?
If you have a uterus, estrogen alone can thicken the lining and raise the risk of endometrial cancer. A progestogen protects against that.
Should a menopause clinic also treat vaginal symptoms?
Yes. Dryness, pain with sex and urinary symptoms are part of menopause and often respond to low-dose vaginal estrogen or non-hormonal treatments.
Is it a red flag if a clinic suggests non-hormonal options?
No, it is a good sign. Non-hormonal treatments are appropriate for some women and should be part of an honest discussion.
How do I know a clinic's longevity tests are worthwhile?
Ask what decision each test will change. Tests that do not affect treatment choices are usually not worth the cost.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- The 2022 hormone therapy position statement of The North American Menopause SocietyThe Menopause Society (PubMed)
- FDA approves labeling changes for menopausal hormone therapy productsU.S. Food and Drug Administration
- Prescribers should restrict the use of non-FDA-approved compounded bioidentical hormones except for specific medical circumstancesNational Academies of Sciences, Engineering, and Medicine
- MenopauseMedlinePlus (National Library of Medicine)
- Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration